Work

Effect of menopausal hormone therapy on components of the metabolic syndrome

Year: 2016

Type: review

Abstract: The world population is aging, and women will spend an increasing share of their lives in a postmenopausal state that predisposes to metabolic dysfunction. Thus, the prevalence of metabolic syndrome (MetS) in women is likely to increase dramatically. This article summarizes the effects of menopause in predisposing to components of MetS including visceral obesity, dyslipidemia, type 2 diabetes (T2D) and hypertension (HTN). We also summarize the effects of menopausal hormone therapy (MHT) in reversing these metabolic alterations and discuss therapeutic advances of novel menopausal treatment on metabolic function.

Source: Therapeutic Advances in Cardiovascular Disease

DOI: 10.1177/1753944716649358

Authors: Dragana Lovre, Sarah H. Lindsey, Franck Mauvais-Jarvis

Institution: Tulane University

Language: English

Topic: Menopause: Health Impacts and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2407239416

FWCI: 0.501

Cites: 81

Cited by: 45

Related to: 10